CompoAtlas

POLLENOX

POLLENOX, licence 80029959: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
9051-1916 Québec Inc. f.a.s.n Le Monde au Naturel
NPN or DIN-HM
80029959
Status
Active licence
Licence date
28 February 2012
Revision date
Not provided
Form
Liquide
Route of administration
Sublinguale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Pituitarium posterium

Source : Lobe postérieur de l'hypophyse

9.0 CHNot calculated
Apis mellifera

Source : Abeilles vivante

15.0 CHNot calculated
Scilla maritima

Source : Bulbe

30.0 CHNot calculated
Pituitarium posterium

Source : Lobe postérieur de l'hypophyse

12.0 CHNot calculated
Sabadilla

Source : Grain(s)

9.0 CHNot calculated

Non-medicinal ingredients

Eau distillée, Alcool éthylique 20%

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 12.0 Année(s)4.0 Pulvérisateurminimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours

Uses authorised in Canada

Remède homéopathique. Indication: Remède homéopathique Indiqué pour soulager les réactions saisonnières, tels que éternuement, congestion ou écoulement nasaux et oculaires, irritation oculaire, palpébrale et trachéale, obstruction nasale par inflammation des muqueuses sinusales et des narines. Prurit du nez, des muqueuses nasales et des paupières avec irritation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80029959

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line